Winston A - Search Results

1

Immediate Versus Deferred Switching From a Boosted Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study.

Gatell JM, Assoumou L, Moyle G, Waters L, Johnson M, Domingo P, Fox J, Martinez E, Stellbrink HJ, Guaraldi G, Masia M, Gompels M, De Wit S, Florence E, Esser S, Raffi F, Stephan C, Rockstroh J, Giacomelli A, Vera J, Bernardino JI, Winston A, Saumoy M, Gras J, Katlama C, Pozniak AL; European Network for AIDS Treatment 022 (NEAT022) Study Group. Gatell JM, et al. Among authors: winston a. Clin Infect Dis. 2019 Feb 1;68(4):597-606. doi: 10.1093/cid/ciy505. Clin Infect Dis. 2019. PMID: 29912307 Clinical Trial.

2

The prevalence and determinants of the K65R mutation in HIV-1 reverse transcriptase in tenofovir-naive patients.

Winston A, Mandalia S, Pillay D, Gazzard B, Pozniak A. Winston A, et al. AIDS. 2002 Oct 18;16(15):2087-9. doi: 10.1097/00002030-200210180-00018. AIDS. 2002. PMID: 12370512

3

Which nucleoside and nucleotide backbone combinations select for the K65R mutation in HIV-1 reverse transcriptase.

Winston A, Pozniak A, Mandalia S, Gazzard B, Pillay D, Nelson M. Winston A, et al. AIDS. 2004 Apr 9;18(6):949-51. doi: 10.1097/00002030-200404090-00014. AIDS. 2004. PMID: 15060444 No abstract available.

4

Dose escalation or immediate full dose when switching from efavirenz to nevirapine-based highly active antiretroviral therapy in HIV-1-infected individuals?

Winston A, Pozniak A, Smith N, Fletcher C, Mandalia S, Parmar D, Gibbons S, Back D, Gazzard B, Nelson M. Winston A, et al. AIDS. 2004 Feb 20;18(3):572-4. doi: 10.1097/00002030-200402200-00029. AIDS. 2004. PMID: 15090815 Clinical Trial.

5

Different methods to calculate the inhibitory quotient of boosted single protease inhibitors and their association with virological response.

Winston A, Patel N, Back D, Khoo S, Bulbeck S, Mandalia S, Pozniak AL, Nelson M, Moyle G, Gazzard B, Boffito M. Winston A, et al. J Acquir Immune Defic Syndr. 2006 Apr 15;41(5):675-6. doi: 10.1097/01.qui.0000209910.27997.d9. J Acquir Immune Defic Syndr. 2006. PMID: 16652044 No abstract available.

6

The clinical implications of antiretroviral pharmacogenomics.

Fox J, Boffito M, Winston A. Fox J, et al. Among authors: winston a. Pharmacogenomics. 2006 Jun;7(4):587-96. doi: 10.2217/14622416.7.4.587. Pharmacogenomics. 2006. PMID: 16753006 Review.

7

Effect of omeprazole on the pharmacokinetics of saquinavir-500 mg formulation with ritonavir in healthy male and female volunteers.

Winston A, Back D, Fletcher C, Robinson L, Unsworth J, Tolowinska I, Schutz M, Pozniak AL, Gazzard B, Boffito M. Winston A, et al. AIDS. 2006 Jun 26;20(10):1401-6. doi: 10.1097/01.aids.0000233573.41597.8a. AIDS. 2006. PMID: 16791014

8

Pharmacokinetics and antiretroviral response to darunavir/ritonavir and etravirine combination in patients with high-level viral resistance.

Boffito M, Winston A, Jackson A, Fletcher C, Pozniak A, Nelson M, Moyle G, Tolowinska I, Hoetelmans R, Miralles D, Gazzard B. Boffito M, et al. Among authors: winston a. AIDS. 2007 Jul 11;21(11):1449-55. doi: 10.1097/QAD.0b013e3282170ab1. AIDS. 2007. PMID: 17589191

9

Polymorphisms at position 245 of HIV reverse transcriptase do not accurately predict the presence of human leukocyte antigen B*5701.

Waters LJ, Mackie NE, Pozniak A, Winston A. Waters LJ, et al. Among authors: winston a. Clin Infect Dis. 2007 Nov 1;45(9):1243-4; author reply 1244-5. doi: 10.1086/521940. Clin Infect Dis. 2007. PMID: 17918094 No abstract available.

10

The associations between age and the development of laboratory abnormalities and treatment discontinuation for reasons other than virological failure in the first year of highly active antiretroviral therapy.

Sabin CA, Smith CJ, Delpech V, Anderson J, Bansi L, Gilson R, Schwenk A, Leen C, Gazzard B, Porter K, Mackie N, Fisher M, Orkin C, Johnson M, Easterbrook P, Hill T, Phillips AN; UK Collaborative HIV Cohort (CHIC) Study. Sabin CA, et al. HIV Med. 2009 Jan;10(1):35-43. doi: 10.1111/j.1468-1293.2008.00654.x. Epub 2008 Nov 10. HIV Med. 2009. PMID: 19018876 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

487 results

Search Page